Evaluation of antiviral activities of Houttuynia cordata Thunb. extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate the in vitro activities of the ethyl acetate (EA) fraction of Houttuynia cordata (H. cordata) Thunb. (Saururaceae) and three of its constituent flavonoids (quercetin, quercitrin and rutin) against murine coronavirus and dengue virus (DENV). METHODS: The antiviral activities of various concentrations of the EA fraction of H. cordata and flavonoids were assessed using virus neutralization tests against mouse hepatitis virus (MHV) and DENV type 2 (DENV-2). Cinanserin hydrochloride was also tested against MHV. The EA fraction of H. cordata was tested for acute oral toxicity in C57BL/6 mice. RESULTS: The EA fraction of H. cordata inhibited viral infectivity up to 6 d. Cinanserin hydrochloride was able to inhibit MHV for only 2 d. The 50% inhibitory concentrations (IC50) of the EA fraction of H. cordata added before the viral adsorption stage were 0.98 μg/mL for MHV and 7.50 μg/mL for DENV-2 with absence of cytotoxicity. The mice fed with the EA fraction up to 2000 mg/kg did not induce any signs of acute toxicity, with normal histological features of major organs. Certain flavonoids exhibited comparatively weaker antiviral activity, notably quercetin which could inhibit both MHV and DENV-2. This was followed by quercitrin which could inhibit DENV-2 but not MHV, whereas rutin did not exert any inhibitory effect on either virus. When quercetin was combined with quercitrin, enhancement of anti-DENV-2 activity and reduced cytotoxicity were observed. However, the synergistic efficacy of the flavonoid combination was still less than that of the EA fraction. CONCLUSIONS: The compounds in H. cordata contribute to the superior antiviral efficacy of the EA fraction which lacked cytotoxicity in vitro and acute toxicity in vivo. H. cordata has much potential for the development of antiviral agents against coronavirus and dengue infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bats Are Natural Reservoirs of SARS-Like Coronaviruses
Li, W., Shi, Z., Yu, M., Ren, W., Smith, C., Epstein, J. H., Wang, H., Crameri, G., Hu, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,560
Guan, Y., Zheng, B. J., He, Y. Q., Liu, X. L., Zhuang, Z. X., Cheung, C. L., Luo, S. W., Li, P. H., Zhang, L. J., Guan, Y. J., et al. (2003) · Science · doi:10.1126/science.1087139 · Cited by 2,406
Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315215 · Cited by 1,632
Flavonoids, a class of natural products of high pharmacological potency
Havsteen, B. (1983) · Biochemical Pharmacology · doi:10.1016/0006-2952(83)90262-9 · Cited by 1,615
Pathogenesis of dengue: challenges to molecular biology
Halstead, S. (1988) · Science · doi:10.1126/science.239.4839.476 · Cited by 1,614
Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats
Lau, S. K. P., Woo, P. C. Y., Li, K. S. M., Huang, Y., Tsoi, H.-W., Wong, B. H. L., Wong, S. S. Y., Leung, S.-Y., Chan, K.-H., & Yuen, K.-Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506735102 · Cited by 1,544
Antiviral effect of catechins in green tea on influenza virus
Song, J.-M., Lee, K.-H., & Seong, B.-L. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.06.010 · Cited by 654
Antiviral effect of flavonoids on human viruses
Kaul, T. N., Middleton, E., & Ogra, P. L. (1985) · Journal of Medical Virology · doi:10.1002/jmv.1890150110 · Cited by 557
Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris
Nguyen, T. T. H., Woo, H.-J., Kang, H.-K., Nguyen, V. D., Kim, Y.-M., Kim, D.-W., Ahn, S.-A., Xia, Y., & Kim, D. (2012) · Biotechnology Letters · doi:10.1007/s10529-011-0845-8 · Cited by 347
Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus
Choi, H.-J., Kim, J.-H., Lee, C.-H., Ahn, Y.-J., Song, J.-H., Baek, S.-H., & Kwon, D.-H. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2008.10.002 · Cited by 225
Hayashi, K., Kamiya, M., & Hayashi, T. (1995) · Planta Medica · doi:10.1055/s-2006-958063 · Cited by 204
Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication
Choi, H. J., Song, J. H., Park, K. S., & Kwon, D. H. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.03.002 · Cited by 203
Wu, C., Calcagno, A. M., Hladky, S. B., Ambudkar, S. V., & Barrand, M. A. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04888.x · Cited by 159
de Sousa, L. R. F., Wu, H., Nebo, L., Fernandes, J. B., da Silva, M. F. D. G. F., Kiefer, W., Kanitz, M., Bodem, J., Diederich, W. E., Schirmeister, T., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.12.015 · Cited by 150
Antiviral effect of flavonoids on the Dengue virus
S�nchez, I., G�mez-Garibay, F., Taboada, J., & Ruiz, B. H. (2000) · Phytotherapy Research · doi:10.1002/(sici)1099-1573(200003)14:2<89::aid-ptr569>3.0.co;2-c · Cited by 130
Molecular evolution of dengue type 2 virus in Thailand.
Rico-Hesse, R. R., Harrison, L. M., Nisalak, A., Vaughn, D. W., Kalayanarooj, S., Green, S., Rothman, A. L., & Ennis, F. A. (1998) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1998.58.96 · Cited by 111
Antiviral Activity of Flavones and Potentiation by Ascorbate
Vrijsen, R., Everaert, L., & Boeyé, A. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-7-1749 · Cited by 110
Houttuynia cordata Targets the Beginning Stage of Herpes Simplex Virus Infection
Hung, P.-Y., Ho, B., Lee, S.-Y., Chang, S., Kao, C., Lee, S., & Lee, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115475 · Cited by 96
Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus
Sutton, T. C., & Subbarao, K. (2015) · Virology · doi:10.1016/j.virol.2015.02.030 · Cited by 96
Dubber, M.-J., & Kanfer, I. (2004) · PubMed · Cited by 89
Atlas of coronavirus replicase structure
Neuman, B. W., Chamberlain, P., Bowden, F., & Joseph, J. S. (2013) · Virus Research · doi:10.1016/j.virusres.2013.12.004 · Cited by 71
Trirawatanapong, T., Chandran, B., Putnak, R. J., & Padmanabhan, R. (1992) · Gene · doi:10.1016/0378-1119(92)90509-n · Cited by 60
Structural basis for antiviral activity of flavonoids-naturally occurring compounds.
Wleklik, M., Łuczak, M., Panasiak, W., Kobus, M., & Lamer-Zarawska, E. (1988) · PubMed · Cited by 41
Lamien, C. E., Meda, A., Mans, J., Romito, M., NACOULMA, O. G., & Viljoen, G. J. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.09.016 · Cited by 36
Mucsi, I. (1984) · PubMed · Cited by 18
Cited by
Important Flavonoids and Their Role as a Therapeutic Agent
Ullah, A., Munir, S., Badshah, S. L., Khan, N., Ghani, L., Poulson, B. G., Emwas, A.-H., & Jaremko, M. (2020) · Molecules · doi:10.3390/molecules25225243 · Cited by 1,696
A role for quercetin in coronavirus disease 2019 (COVID‐19)
Derosa, G., Maffioli, P., D'Angelo, A., & Di Pierro, F. (2021) · Phytotherapy Research · doi:10.1002/ptr.6887 · Cited by 303
Mirzaie, A., Halaji, M., Dehkordi, F. S., Ranjbar, R., & Noorbazargan, H. (2020) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2020.101214 · Cited by 164
Sun, D., Zhou, X., Wu, T., Li, Z., Huang, S., & Peng, Z. (2026) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/0115748928318948240920044716 · Cited by 13
Metadata
- Authors
- Chiow, K. H., Phoon, M. C., Putti, T., Tan, B. K. H., & Chow, V. T.
- Venue
- Asian Pacific Journal of Tropical Medicine
- Published
- 2016-01
- Volume
- 9
- Issue
- 1
- Pages
- 1-7
- ISSN
- 1995-7645 (ISSN-L)
- OpenAlex
- W2215640744
- Cited by
- 272
- References
- 25
- FWCI
- 8.89
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.